Emergent BioSolutions signs $174 million deal to make AstraZeneca#39;s potential COVID-19 vaccine

Emergent BioSolutions signs $174 million deal to make AstraZeneca#39;s potential COVID-19 vaccine
Emergent BioSolutions signs $174 million deal to make AstraZeneca#39;s potential COVID-19 vaccine AstraZeneca in June picked Emergent to help produce 300 million doses of its potential COVID-19 vaccine pledged to the United States.